Reported Jun 25, 2014 · Terminated

Vancomycin Hydrochloride Capsules, USP, 250 mg. 20 Capsules on 2 x 10 Capsule Blister Cards, Rx Only. Mfd. for: Watson…

Actavis Inc.

Moderate riskThis product could cause temporary or reversible health problems — stop using it.

What you should do

Stop using the affected lot and contact the recalling firm for the return or refund process. Check the FDA enforcement report for lot-level detail.

Firm contact: Actavis Inc · 400 Interpace Pkwy · Parsippany, NJ · 07054-1120

Is this the product you have?

  • Vancomycin Hydrochloride Capsules, USP, 250 mg. 20 Capsules on 2 x 10 Capsule Blister Cards, Rx Only. Mfd
  • forWatson Pharma Inc., Parsippany, NJ 07054 USA. Mfd
  • byPatheon Pharmaceuticals Inc., Cincinnati, OH 45237 USA. NDC 0591-3561-15
Lot codes and dates
  • Lot #: 3100135
  • Expiry05/2014
Amount recalled
6913 packages

Where it was sold

  • Nationwide

Why it was recalled

Subpotent Drug.

This product could cause temporary or reversible health problems — stop using it.

Want the full recall guide?

The guide adds the identifying codes laid out for scanning, symptoms to watch for, a timeline, and news coverage of this recall.

Free recall alerts

Get alerted about new Actavis Inc. recalls

One email when a matching recall is published. No account, no cost, unsubscribe in one click.

Where this came from

Source: U.S. Food & Drug Administration (openFDA)

Read the FDA (openFDA drug enforcement) notice

Notice updated Feb 23, 2015 · Data as of Sep 19, 5:02 PM UTC

RecallNow is not a government agency. Every fact on this page is published by the FDA, USDA or CPSC and links back to their notice.